Full text is available at the source.
Abstract
Microphysiological Systems (MPS) may provide high physiological relevance for drug discovery and pharmacokinetic studies.
- MPS technology includes organoids and organ-on-a-chip (OoC) systems, which simulate organ function.
- Organoids are formed from 3D cell aggregates, while OoCs utilize microfluidic platforms to replicate in vivo environments.
- Current challenges exist in making MPS reliable alternatives to animal testing.
- MPS technology is not yet fully comparable to in vivo systems.
- Advancements may be supported by in silico methods, automation, and AI approaches.
Simplified